File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.oraloncology.2013.11.005
- Scopus: eid_2-s2.0-84898834624
- PMID: 24333100
- WOS: WOS:000334583600006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Translational research in nasopharyngeal carcinoma
Title | Translational research in nasopharyngeal carcinoma |
---|---|
Authors | |
Keywords | NPC EBV Angiogenesis Growth factor receptor Targeted therapy |
Issue Date | 2014 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology |
Citation | Oral Oncology, 2014, v. 50 n. 5, p. 345-352 How to Cite? |
Abstract | Nasopharyngeal carcinoma is well known to be a viral driven malignancy. Despite high loco-regional control rate with modern radiotherapy, distant metastasis remains as a major threat to the patients highlighting the importance of effective systemic therapy. Recent advances in the understanding of tumor biology, host cell–virus interaction and genetics have paved new ways for targeted therapies. This review summarizes the recent advances into our knowledge and understanding of NPC and highlights potential novel therapeutic strategies that may prove useful to treat this disease. |
Persistent Identifier | http://hdl.handle.net/10722/198063 |
ISSN | 2023 Impact Factor: 4.0 2023 SCImago Journal Rankings: 1.257 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chiang, AKS | - |
dc.contributor.author | Mak, NK | - |
dc.contributor.author | Ng, WT | - |
dc.date.accessioned | 2014-06-25T02:43:49Z | - |
dc.date.available | 2014-06-25T02:43:49Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Oral Oncology, 2014, v. 50 n. 5, p. 345-352 | - |
dc.identifier.issn | 1368-8375 | - |
dc.identifier.uri | http://hdl.handle.net/10722/198063 | - |
dc.description.abstract | Nasopharyngeal carcinoma is well known to be a viral driven malignancy. Despite high loco-regional control rate with modern radiotherapy, distant metastasis remains as a major threat to the patients highlighting the importance of effective systemic therapy. Recent advances in the understanding of tumor biology, host cell–virus interaction and genetics have paved new ways for targeted therapies. This review summarizes the recent advances into our knowledge and understanding of NPC and highlights potential novel therapeutic strategies that may prove useful to treat this disease. | - |
dc.language | eng | - |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology | - |
dc.relation.ispartof | Oral Oncology | - |
dc.subject | NPC | - |
dc.subject | EBV | - |
dc.subject | Angiogenesis | - |
dc.subject | Growth factor receptor | - |
dc.subject | Targeted therapy | - |
dc.title | Translational research in nasopharyngeal carcinoma | - |
dc.type | Article | - |
dc.identifier.email | Chiang, AKS: chiangak@hku.hk | - |
dc.identifier.email | Ng, WT: ngwt1@hkucc.hku.hk | - |
dc.identifier.authority | Chiang, AKS=rp00403 | - |
dc.identifier.authority | Ng, WT=rp02671 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.oraloncology.2013.11.005 | - |
dc.identifier.pmid | 24333100 | - |
dc.identifier.scopus | eid_2-s2.0-84898834624 | - |
dc.identifier.hkuros | 229249 | - |
dc.identifier.volume | 50 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 345 | - |
dc.identifier.epage | 352 | - |
dc.identifier.isi | WOS:000334583600006 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1368-8375 | - |